A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA
Clinical trial NCT06588803 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06588803
- Sponsor
- Guangzhou Jiayin Biotech Ltd
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-01
- Primary completion
- 2030-09-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.